- Home
- SNY vs IBN Comparison
SNY vs IBN Comparison
Compare SNY & IBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- IBN
- Stock Information
- Founded
- SNY 1994
- IBN 1955
- Country
- SNY France
- IBN India
- Employees
- SNY N/A
- IBN N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- IBN Commercial Banks
- Sector
- SNY Health Care
- IBN Finance
- Exchange
- SNY Nasdaq
- IBN Nasdaq
- Market Cap
- SNY 140.6B
- IBN 98.9B
- IPO Year
- SNY N/A
- IBN 1999
- Fundamental
- Price
- SNY $57.73
- IBN $28.56
- Analyst Decision
- SNY Buy
- IBN
- Analyst Count
- SNY 2
- IBN 0
- Target Price
- SNY $57.50
- IBN N/A
- AVG Volume (30 Days)
- SNY 1.6M
- IBN 4.4M
- Earning Date
- SNY 10-25-2024
- IBN 10-21-2024
- Dividend Yield
- SNY 3.53%
- IBN 0.83%
- EPS Growth
- SNY N/A
- IBN 21.08
- EPS
- SNY 3.60
- IBN 0.76
- Revenue
- SNY $50,444,658,733.00
- IBN $20,234,981,353.00
- Revenue This Year
- SNY $3.58
- IBN N/A
- Revenue Next Year
- SNY $6.99
- IBN $14.78
- P/E Ratio
- SNY $32.20
- IBN $18.65
- Revenue Growth
- SNY 2.25
- IBN 23.97
- 52 Week Low
- SNY $42.63
- IBN $21.89
- 52 Week High
- SNY $58.97
- IBN $29.72
- Technical
- Relative Strength Index (RSI)
- SNY 71.75
- IBN 48.48
- Support Level
- SNY $55.80
- IBN $28.83
- Resistance Level
- SNY $58.97
- IBN $29.72
- Average True Range (ATR)
- SNY 0.58
- IBN 0.26
- MACD
- SNY 0.16
- IBN 0.07
- Stochastic Oscillator
- SNY 74.38
- IBN 37.99
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
About IBN ICICI Bank Limited
ICICI Bank Ltd provides banking services. The company's operating segments include Retail Banking; Wholesale Banking; Treasury, Life insurance, and Other Banking Businesses. The company generates maximum revenue from the Retail Banking segment which includes exposures of the Bank, which satisfy the four qualifying criteria of a regulatory retail portfolio as stipulated by RBI guidelines on the Basel III framework as well as includes income from credit cards, debit cards, third party product distribution, and the associated costs.